EV/EBITDA:
-8.12+0.16(+1.93%)Summary
- As of today, CRSP EV/EBITDA is -8.12, with a rise of +0.16 (+1.93%) during the current trading session.
- Over the past year, CRSP EV/EBITDA has increased by +0.16 (+1.93%).
- CRSP EV/EBITDA is now -100.38% below its all-time high of 2142.90.
Performance
CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.9% | -2.0% | -1.4% |
| 1M1 Month | +23.7% | -23.7% | -17.9% |
| 3M3 Months | -0.1% | +0.1% | +0.0% |
| 6M6 Months | -129.4% | +120.5% | +47.8% |
| YTDYTD | -114.3% | +109.4% | +41.3% |
| 1Y1 Year | +1.9% | +37.0% | +10.4% |
| 5Y5 Years | +69.1% | -40.7% | -46.2% |
CRSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.10 | -0.3% | -12.52 | +35.1% |
| 3M | 3-Month | -7.33 | -10.8% | -12.52 | +35.1% |
| 6M | 6-Month | -2.69 | -201.9% | -12.52 | +35.1% |
| 1Y | 1-Year | -2.33 | -248.5% | -12.52 | +35.1% |
| 3Y | 3-Year | -2.13 | -281.2% | -33.74 | +75.9% |
| 5Y | 5-Year | 21.60 | -137.6% | -48.40 | +83.2% |
| All-Time | All-Time | 2142.90 | -100.4% | -759.60 | +98.9% |
CRSP EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.12(-114.2%) |
| 2024 | -3.79(+80.9%) |
| 2023 | -19.83(-693.2%) |
| 2022 | -2.50(-126.6%) |
| 2021 | 9.40(+133.5%) |
| Date | Value |
|---|---|
| 2020 | -28.06(-151.6%) |
| 2019 | 54.42(+925.8%) |
| 2018 | -6.59(+43.1%) |
| 2017 | -11.59(-59.0%) |
| 2016 | -7.29 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all-time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -8.12
What is the all-time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2142.90
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by -4.33 (-114.25%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by +0.16 (+1.93%)